文献速递眼底病与葡萄膜炎

生殖生命周期与女性特异性葡萄膜炎活动模式:来自AIDA网络葡萄膜炎登记处的数据

Reproductive Life Stages and Female Sex-Specific Patterns in Uveitis Activity: Data From the AIDA Network Uveitis Registry.
PubMed 文献 · Am J Ophthalmol · 2025-11-14

该观察性、回顾性、横断面登记研究基于AIDA网络葡萄膜炎登记处2020至2025年数据,纳入425例女性非感染性葡萄膜炎患者和275例男性对照,按年龄区间近似划分生殖生命周期阶段。结果显示复发次数在各阶段间存在差异(P=0.014),生殖生命周期与性别存在交互作用(P=0.044),围绝经期复发峰值仅见于女性;青春期前及青春期早期前房炎症更重(P=0.004),青春期前及青春期免疫抑制治疗暴露比例更高(P=0.012)。作者认为生殖生命周期是葡萄膜炎活动的临床相关修饰因素,应指导患者教育、风险分层和治疗。

要点

  • 生殖生命周期与性别存在交互作用(P=0.044),围绝经期复发峰值仅见于女性。
  • 12个月内复发次数在各生殖生命周期阶段间差异有统计学意义(P=0.014)。
  • 青春期前和青春期早期前房炎症更重(P=0.004),且免疫抑制治疗暴露比例更高(P=0.012)。

核心结论

  • 生殖生命周期是葡萄膜炎活动的临床相关修饰因素,应指导患者教育、风险分层和治疗。
  • 青春期早期和围绝经期增加复发风险;儿科病例前房炎症更重且需要更多全身免疫抑制治疗。

研究设计与样本

  • 观察性、回顾性、横断面登记研究,纳入AIDA网络葡萄膜炎登记处2020至2025年的女性非感染性葡萄膜炎患者425例和男性对照275例。
  • 生殖生命周期(青春期前、青春期早期、青春期晚期、育龄期、围绝经期、绝经后)用基于流行病学数据推导的年龄区间近似划分。
  • 研究结局为复发频率、前房细胞、前房闪辉、玻璃体混浊、新发后节炎症体征和免疫抑制治疗暴露。

主要发现

  • 12个月内复发次数中位数(IQR)在青春期前为0.8(1.3)[最小0.0-最大2.0],青春期早期为1.0(2.0)[0.0-5.0],青春期晚期为0.0(1.0)[0.0-5.0],育龄期为0.5(1.0)[0.0-8.0],围绝经期为1.0(1.0)[0.0-10.0],绝经后为0.5(1.0)[0.0-7.5](P=0.014)。
  • 生殖生命周期与性别之间存在统计学显著交互作用(P=0.044),围绝经期复发峰值仅保留在女性中。
  • 在有活动性前节受累的受试者中,前房细胞分级在各生殖生命周期阶段间的分布存在差异,峰值见于青春期前和青春期早期(P=0.004)。
  • 接受免疫抑制治疗的受试者比例在青春期前和青春期高于其余生殖生命周期阶段(P=0.012)。

临床怎么用

  • 作者认为生殖生命周期是葡萄膜炎活动的临床相关修饰因素,应指导患者教育、风险分层和治疗。
  • 作者认为青春期早期和围绝经期增加复发风险;儿科病例前房炎症更重且需要更多全身免疫抑制治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE OR PURPOSE: To investigate whether noninfectious uveitis (NIU) activity varies across reproductive life stages (RLS) according to sex. DESIGN: Observational, retrospective, cross-sectional registry-based study. SUBJECTS, PARTICIPANTS, AND/OR CONTROLS: The study recruited female patients with NIU (regardless of anatomical location or underlying etiology) as the main study group and male patients as controls to allow sex-based comparisons. They were enrolled in the AIDA Network Uveitis Registry between 2020 and 2025. METHODS, INTERVENTION, OR TESTING: RLS (prepuberal, early puberty, late puberty, reproductive, perimenopause, and podtmenopausal) were approximated using age intervals derived from epidemiological data. Study outcomes were flare frequency, anterior chamber cells (ACC), anterior chamber flare, vitreous haze, new posterior segment inflammatory signs, and immunosuppressive treatment (IST) exposure. RESULTS: Four hundred twenty-five female and 275 male patients were included. Median (IQR) relapse number in 12 months was 0.8 (1.3) [min 0.0-max 2.0] in prepuberty, 1.0 (2.0) [0.0-5.0] in early puberty, 0.0 (1.0) [0.0-5.0] in late puberty, 0.5 (1.0) [0.0-8.0] in reproductive age, 1.0 (1.0) [0.0-10.0] in perimenopause, and 0.5 (1.0) [0.0-7.5] in post-menopause (P = .014). There was a statistically significant interaction between RLS and sex (P = .044), with a perimenopausal peak retained only in women. In subjects with active anterior involvement, differences in the distribution of ACC grades among RLS were observed, with a peak in prepuberty and early puberty (P = .004). Proportions of subjects receiving IST were higher in prepuberty and puberty than in the remaining RLS (P = .012). CONCLUSIONS: RLS are clinically relevant modifiers of uveitis activity and should guide patient education, risk stratification, and therapy. Early puberty and perimenopause increase relapse risk; pediatric cases show more severe anterior inflammation and require more systemic IST.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Gaggiano C, DE-LA-Torre A, Guerriero S, et al. Reproductive Life Stages and Female Sex-Specific Patterns in Uveitis Activity: Data From the AIDA Network Uveitis Registry. Am J Ophthalmol. 2025. PMID: 41242592. doi:10.1016/j.ajo.2025.11.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。